Table 2 Urinary concentrations of phthalates and BPA in girls with CPP and control groups
From: The analysis of endocrine disruptors in patients with central precocious puberty
CPP (N = 47) | Pre-pubertal control (N = 26) | P value | CPP (N = 47) | Pubertal control (N = 21) | P value | |
|---|---|---|---|---|---|---|
MBzP (μg/g creatinine) | 3.1 (1.8–4.9) | 4.3 (3.3–11.1) | 0.026 | 3.1 (1.8–4.9) | 1.7 (0.64–4.6) | 0.077 |
MECPP (μg/g creatinine) | 29.3 (22.1–44.7) | 53.7 (35.1–86.4) | < 0.001 | 29.3 (22.1–44.7) | 28.7 (22.7–45.6) | 0.733 |
MEHHP (μg/g creatinine) | 18.0 (14.6–28.5) | 35.7 (23.0–54.3) | 0.001 | 18.0 (14.6–28.5) | 21.4 (13.5–29.4) | 0.762 |
MEOHP (μg/g creatinine) | 15.4 (12.1–25.0) | 29.1 (18.7–35.9) | < 0.001 | 15.4 (12.1–25.0) | 12.1 (8.0–17.8) | 0.405 |
MnBP (μg/g creatinine) | 25.2 (10.9–151.0) | 66.0 (39.4–106.1) | < 0.001 | 25.15 (10.92–150.98) | 33.3 (25.2–46.2) | 0.981 |
Bisphenol A (μg/g creatinine) | 0.63 (0.4–1.1) | 2.0 (0.93–3.5) | < 0.001 | 0.63 (0.4–1.1) | 1.7 (1.1–3.3) | 0.092 |